Cyp2d6 Phenotyping

CYP2D6 Phenotyping is a pharmacogenetic assessment method that classifies individuals based on their metabolic activity of the CYP2D6 enzyme, determined through the measurement of probe drug metabolism or phenotypic markers, to infer functional enzyme status distinct from genotypic prediction alone.

503

Publications

27.4K

Citations

2.7K

Authors

917

Institutions

Publications per year

2017–2026

101

Authors

2.7K

  1. AG
    Andrea Gaedigk

    Children's Mercy Hospital, United States

    32 publications · 4.1K citations

    23

    h-index

  2. JS
    J. Steven Leeder

    Children's Mercy Hospital, United States

    19 publications · 2.2K citations

    17

    h-index

  3. AL
    Adrián LLerena

    Universidad de Extremadura, Spain

    20 publications · 759 citations

    16

    h-index

  4. MS
    Matthias Schwab

    Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Germany

    14 publications · 1.5K citations

    14

    h-index

  5. PD
    Pedro Dorado

    Universidad de Extremadura, Spain

    13 publications · 510 citations

    13

    h-index

1–5 of 2.7K

Venues

  1. Clinical Pharmacology & Therapeutics

    CPT · 54 publications · 6K citations

    36

    h-index

  2. Pharmacogenetics

    35 publications · 2.3K citations

    28

    h-index

  3. British Journal of Clinical Pharmacology

    BJCP · 26 publications · 1.8K citations

    22

    h-index

  4. European Journal of Clinical Pharmacology

    21 publications · 866 citations

    19

    h-index

  5. Pharmacogenomics

    23 publications · 699 citations

    16

    h-index

1–5